Necrosis Clinical Trials

Find Necrosis Clinical Trials Near You

Pre-operative Intra-nasal Dexmedetomidine or Insulin for Prevention of Early Post-operative Cognitive Dysfunction in Patients Undergoing Elective Coronary Artery Bypass Graft. A Comparative Randomized Bi-centric Study

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY

On pump coronary revascularization is a very common leading cause for post-operative cognitive dysfunction regarding patient age grouping and diffuse systemic inflammatory response induced by bypass machine . Many factors are incriminated as pre-operative sleep disturbance, previous history of neurocognitive dysfunction. The accumulating evidence refers to an incidence between 20-40% with majority among geriatric population. The primary pathology is still elusive and many trials are under evaluation. Neuro-inflammation, hypo perfusion, fat emboli and reperfusion injury are among the most postulative aetiologias. The corner stone in the pathology of postoperative cognitive dysfunction is abnormal sleep rhythm. Intra-nasal insulin can provide neuroprotection via providing insulin growth factor and obtund neuronal apoptosis , while dexmedetomidine can antagonize neural-degeneration via regulation of systematic inflammatory cytokines including interleukin 1β, tumor necrosis factor-α, and NF-κB, inhibiting the expressions of Toll-like receptor , and through α2 adrenoceptor-mediated anti-inflammatory pathways

Eligibility
Participation Requirements
Sex: All
Minimum Age: 60
Maximum Age: 75
Healthy Volunteers: f
View:

• Adult population, 60 years or above, both sex, candidate for elective on pump coronary revascularization

Locations
Other Locations
Egypt
Fayoum university
RECRUITING
Al Fayyum
Contact Information
Primary
mina raouf, MD
drmina2015@gmail.com
01015752424
Time Frame
Start Date: 2024-12-27
Estimated Completion Date: 2026-05-15
Participants
Target number of participants: 150
Treatments
Placebo_comparator: Control group
Active_comparator: Insulin group
Active_comparator: Dexmedetomidine group
Sponsors
Leads: Minia University

This content was sourced from clinicaltrials.gov